161 related articles for article (PubMed ID: 35990519)
1. Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion.
Papadakos KS; Lundgren S; Gialeli C; Micke P; Mezheyeuski A; Elebro J; Jirström K; Blom AM
Oncoimmunology; 2022; 11(1):2111906. PubMed ID: 35990519
[TBL] [Abstract][Full Text] [Related]
2. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM
Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861
[TBL] [Abstract][Full Text] [Related]
3. Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression.
Blom AM; Gialeli C; Hagerling C; Berntsson J; Jirström K; Papadakos KS
Front Immunol; 2023; 14():1167659. PubMed ID: 37207219
[TBL] [Abstract][Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
5. Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater.
Kim MH; Jang M; Kim H; Lee WJ; Kang CM; Choi HJ
Cancer Immunol Immunother; 2019 Mar; 68(3):443-454. PubMed ID: 30604042
[TBL] [Abstract][Full Text] [Related]
6. Role of Immunohistochemistry in the Subtyping of Periampullary Adenocarcinoma.
Bakshi N; Dhawan S; Nundy S; Rao S; Chopra P; Bhalla S
Int J Surg Pathol; 2019 Sep; 27(6):598-608. PubMed ID: 30942099
[No Abstract] [Full Text] [Related]
7. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma.
Sandhu V; Bowitz Lothe IM; Labori KJ; Skrede ML; Hamfjord J; Dalsgaard AM; Buanes T; Dube G; Kale MM; Sawant S; Kulkarni-Kale U; Børresen-Dale AL; Lingjærde OC; Kure EH
Mol Oncol; 2016 Feb; 10(2):303-16. PubMed ID: 26590090
[TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
10. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
11. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
12. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
13. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
14. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
15. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils.
Khayyata S; Basturk O; Adsay NV
Mod Pathol; 2005 Nov; 18(11):1504-11. PubMed ID: 16007065
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract][Full Text] [Related]
18. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
19. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
[TBL] [Abstract][Full Text] [Related]
20. [Contrastive study on MRI signs of intestinal and pancreatobiliary-type periampullary carcinoma].
Zhu QJ; He J; Li Q; Yan CC
Zhonghua Yi Xue Za Zhi; 2022 May; 102(18):1351-1358. PubMed ID: 35545578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
